Home
Biotechnology Value Fund reported a 1.8% stake in enGene Therapeutics ENGN · 945,402 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 1.8%
- Last report
- 5.9% · filed 25/01/29
- Shares held
- 945,402 sh
- Class
- Common Shares, no par value per share
- Holder
- Biotechnology Value Fund
- Event date
- 25/01/27
- Filed
- 25/01/29
1.8% stake · below 5%
- Stake
- 1.8%
- Last report
- 5.9%
- Since last report
- −4.1pp
enGene Therapeutics trades, last 26 weeks
What else happened in enGene Therapeutics around then
Filed or reported within 30 days of the trade day · 24/12/28~25/02/26Biotechnology Value Fund's other 5% stake reports
- Biotechnology Value Fund
5% stakeStoke Therapeutics
5% stakeStoke Therapeutics
STOK
5.6% stake
3,608,968 sh
5.6% stake
Filed 09/30
- Biotechnology Value Fund
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
6.1% stake
4,215,886 sh
6.1% stake
Filed 09/21
- Biotechnology Value Fund
5% stakeAlector
5% stakeAlector
ALEC
8.4% stake
9,374,267 sh
8.4% stake
Filed 09/18
- Biotechnology Value Fund
5% stakePalvella Therapeutics
5% stakePalvella Therapeutics
PVLA
4.7% stake
672,789 sh
4.7% stake
Filed 08/14
- Biotechnology Value Fund
5% stakeOnKure Therapeutics
5% stakeOnKure Therapeutics
OKUR
8% stake
3,235,778 sh
8% stake
Filed 08/14
